v3.25.2
Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Preferred Stock
Series B
Common Stock
Common Stock to be Issued
Additional Paid-in Capital
Treasury Stock
Accumulated Other Comprehensive Gain (Loss)
Accumulated Deficit
Noncontrolling Interest
Total
Balance at Dec. 31, 2023 $ 200 $ 210 $ 54,597,083 $ (397,969) $ 34,553 $ (48,134,088) $ 6,099,989
Balance (in Shares) at Dec. 31, 2023 2,000,000 2,103,321 139            
Accretion of stock based compensation in connection with stock option grants 6,695 6,695
Accretion of stock based professional fees in connection with stock option grants 22,019 22,019
Issuance of common shares in subsidiary for services 22,500 22,500
Issuance of common stock for cash, net of allocated offering costs $ 39 559,212 559,251
Issuance of common stock for cash, net of allocated offering costs (in Shares)   382,972              
Sale of pre-funded warrants, net of allocated offering costs of $229,919 861,522 861,522
Cashless exercise of pre-funded warrants $ 59 (59)
Cashless exercise of pre-funded warrants (in Shares)   589,981              
Initial recording on noncontrolling interest 442,361 (442,361)
Accumulated other comprehensive loss (34,553) (34,553)
Net loss for the period (1,137,812) (423,995) (1,561,807)
Balance at Mar. 31, 2024 $ 200 $ 308 56,511,333 (397,969) (49,271,900) (866,356) 5,975,616
Balance (in Shares) at Mar. 31, 2024 2,000,000 3,076,274 139            
Balance at Dec. 31, 2023 $ 200 $ 210 54,597,083 (397,969) 34,553 (48,134,088) 6,099,989
Balance (in Shares) at Dec. 31, 2023 2,000,000 2,103,321 139            
Net loss for the period                 (2,765,915)
Balance at Jun. 30, 2024 $ 200 $ 308 56,772,699 $ (397,969) (50,255,147) (1,087,217) 5,032,874
Balance (in Shares) at Jun. 30, 2024 2,000,000 3,076,274 139            
Balance (in Shares)         66,945        
Balance at Mar. 31, 2024 $ 200 $ 308 56,511,333 $ (397,969) (49,271,900) (866,356) 5,975,616
Balance (in Shares) at Mar. 31, 2024 2,000,000 3,076,274 139            
Accretion of stock based compensation in connection with stock option grants 3,349 3,349
Accretion of stock based professional fees in connection with stock option grants 22,019 22,019
Issuance of common shares in subsidiary for cash 235,998 235,998
Net loss for the period (983,247) (220,861) (1,204,108)
Balance at Jun. 30, 2024 $ 200 $ 308 56,772,699 $ (397,969) (50,255,147) (1,087,217) $ 5,032,874
Balance (in Shares) at Jun. 30, 2024 2,000,000 3,076,274 139            
Balance (in Shares)         66,945        
Balance (in Shares)                 66,945
Balance at Dec. 31, 2024 $ 200 $ 308 59,649,645 $ (397,969) (52,373,248) (2,137,789) $ 4,741,147
Balance (in Shares) at Dec. 31, 2024 2,000,000 3,076,274 139            
Accretion of stock based compensation in connection with stock option grants 155,054 155,054
Issuance of common stock for cash, net of allocated offering costs $ 120 4,531,880 4,532,000
Issuance of common stock for cash, net of allocated offering costs (in Shares)   1,200,000              
Initial recording on noncontrolling interest 188,810 (188,810)
Net loss for the period (1,473,196) (145,914) (1,619,110)
Balance at Mar. 31, 2025 $ 200 $ 428 64,525,389 (397,969) (53,846,444) (2,472,513) 7,809,091
Balance (in Shares) at Mar. 31, 2025 2,000,000 4,276,274 139            
Balance at Dec. 31, 2024 $ 200 $ 308 59,649,645 (397,969) (52,373,248) (2,137,789) 4,741,147
Balance (in Shares) at Dec. 31, 2024 2,000,000 3,076,274 139            
Net loss for the period                 (2,976,299)
Balance at Jun. 30, 2025 $ 200 $ 428 64,676,721 $ (397,969) (55,063,316) (2,605,550) 6,610,514
Balance (in Shares) at Jun. 30, 2025 2,000,000 4,276,274 139            
Balance (in Shares)         66,945        
Balance at Mar. 31, 2025 $ 200 $ 428 64,525,389 $ (397,969) (53,846,444) (2,472,513) 7,809,091
Balance (in Shares) at Mar. 31, 2025 2,000,000 4,276,274 139            
Accretion of stock based compensation in connection with stock option grants 157,120 157,120
Accretion of stock based professional fees in connection with stock option grants 1,492 1,492
Changes in noncontrolling interest (7,280) 7,280
Net loss for the period (1,216,872) (140,317) (1,357,189)
Balance at Jun. 30, 2025 $ 200 $ 428 $ 64,676,721 $ (397,969) $ (55,063,316) $ (2,605,550) $ 6,610,514
Balance (in Shares) at Jun. 30, 2025 2,000,000 4,276,274 139            
Balance (in Shares)         66,945       66,945